Jiangsu, China

Junfeng Li

This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Innovent Biologics, Inc., Innovent Biologics (Suzhou) Co., Ltd., Visionox Technology Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junfeng Li. Retrieved from https://idiyas.com/inventor/junfeng-li-ziomgu9x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Junfeng Li

Introduction

Junfeng Li is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations. With a total of 4 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Among his latest patents is a formulation for PD-1 antibodies, which provides pharmaceutical formulations that enhance the efficacy of anti-PD-1 therapies. Additionally, he has developed stable liquid formulations for recombinant fusion proteins, which enable the stable storage of these proteins, comprising a recombinant fusion protein, a buffer salt, a stabilizer, and a surfactant.

Career Highlights

Junfeng Li has worked with prominent companies in the biotechnology sector, including Innovent Biologics, Inc. and Innovent Biologics (Suzhou) Co., Ltd. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

He has collaborated with esteemed colleagues such as Yinjue Wang and Xiaole Huang, further enhancing the innovative work being done in his field.

Conclusion

Junfeng Li's contributions to pharmaceutical innovations, particularly in antibody formulations, highlight his role as a significant inventor in the industry. His work continues to influence advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…